Current Report
Filed: 2026-05-12
Key Insights
- Curis announced Q1 2026 financial results on May 12, 2026, with the full details provided in the press release exhibit (99.1), though the specific financial metrics and performance data are not visible in this 8-K cover filing.
- The company is listed on the Nasdaq Capital Market under ticker CRIS, indicating it is a smaller-cap biotech/pharmaceutical firm that may face liquidity or investor base constraints compared to larger exchanges.
- James E. Dentzer, President and CEO, signed the filing, confirming continued stable leadership during what appears to be a routine quarterly earnings announcement with no material events or transactions reported.